Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

The next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen.

Eli Lilly reported Q3 revenue and earnings that fell short of analysts' expectations. Mounjaro and Zepbound faced challenges as U.S. wholesalers reduced inventories of the drugs. The bull case for ...

Eli Lilly’s Third Quarter Earnings Miss and Forecast Cut Lead to Sharp Stock Drop INDIANAPOLIS (AP) — Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third ...

(Reuters) -Eli Lilly's high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies sat in warehouses, a 180-degree turn for the company after long ...

The injection pen is a medical device used for injecting ... and introduction of new drugs such as Mounjaro from Eli Lilly- has propelled market development. The push for self-administration ...

(MENAFN- GlobeNewsWire - Nasdaq) The global injection pen market is expanding at a fast ... of new drugs such as Mounjaro from Eli Lilly- has propelled market development. The push for self ...

A group of U.S. senators is digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ... actions of the prescribing pen.” The senators are requesting ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity ...